Date: Wed, May 07, 2025 | 06:05 PM GMT

After a brutal Q1 where Ethereum (ETH) alone crashed 45%, the crypto market is finally showing signs of life again. ETH has rebounded by over 31% from its April 9 low—and it’s not alone. Injective (INJ), a standout in the altcoin space, has gained nearly 29% over the past month.

However, in weekly performance, INJ's momentum has cooled. So, what’s really going on? Is this just a healthy pause—or could another bearish leg be incoming?

Source: Coinmarketcap

Well, the charts might be hinting at something much more optimistic.

A Bullish Inverse Head and Shoulders Is Taking Shape

On the daily chart, $INJ appears to be forming a classic Inverse Head and Shoulders pattern—a technical setup that often signals a bullish reversal. This pattern suggests that the selling pressure is drying up and a trend shift might be in the cards.

Here’s how it breaks down:

Injective (INJ) Daily Chart/Coinsprobe (Source: Tradingview)

Left Shoulder: INJ found support around $8.14 in mid-March after failing to break above the $10 zone.

Head: Bears took control in early April, pushing the token down to a low of $6.34—the deepest point in the pattern.

Right Shoulder: Now, INJ is holding steady above the 0.382 ($9.00) and 0.5 ($8.50) Fibonacci retracement levels. The 50-day moving average is also lending support, acting as a dynamic floor around $9.02–$9.35.

What’s Next for INJ?

If the pattern completes and INJ breaks above the neckline—which lies around the $10–$10.50 range—it could trigger a strong upward move. The technical target for this setup is around $14–$14.50, representing a potential 53% rally from current levels.

This move aligns with the green target circle plotted on the chart, suggesting that bulls may already have their eyes on that zone.

However, if INJ fails to hold the support zone near the 0.5 Fib level and breaks below the right shoulder, the pattern may get invalidated—potentially putting more downward pressure in the short term.

Disclaimer: This article is for informational purposes only and not financial advice. Always do your own research before making any investment decisions.